Form 4: Stitch Fix Chief Product and Technology Officer Executes Pre-Planned Stock Option Exercise and Share Sales

Stitch Fix's Chief Product and Technology Officer, Anthony Bacos, exercised stock options and subsequently sold a portion of his Class A Common Stock shares on July 22, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.

Summary

• Anthony Bacos, Chief Product and Technology Officer of Stitch Fix, Inc. (SFIX), engaged in transactions involving the company's Class A Common Stock on July 22, 2025.
• Bacos exercised employee stock options to acquire 60,000 shares of Class A Common Stock at an exercise price of $3.99 per share.
• Following the option exercise, Bacos sold a total of 90,000 shares of Class A Common Stock.
• The first sale involved 60,000 shares at a weighted average price of $5.0035 per share, with individual sale prices ranging from $5.00 to $5.02.
• The second sale involved 30,000 shares at a weighted average price of $5.0045 per share, with individual sale prices ranging from $5.00 to $5.01.
• All reported transactions, including both the option exercise and the share sales, were conducted pursuant to a Rule 10b5-1 trading plan that was established on March 13, 2025.
• After these transactions, Bacos directly beneficially owns 829,966 shares of Class A Common Stock and 662,543 employee stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there's a sale of shares, it's part of a pre-planned Rule 10b5-1 program, which mitigates negative interpretations. The officer also exercised options, indicating value capture.

Positives

• The exercise of stock options allowed the officer to realize value from previously granted equity, indicating a prior commitment to the company's long-term performance.
• The transactions were executed under a pre-arranged Rule 10b5-1 plan, which provides transparency and suggests a systematic approach to managing equity rather than a reaction to immediate market conditions or non-public information.

Negatives

• The sale of 90,000 shares by a Chief Product and Technology Officer represents a reduction in direct equity exposure, which some investors might interpret as a slight negative, despite being pre-planned.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May view the sale as a reduction in insider ownership, but the Rule 10b5-1 plan provides transparency and suggests a pre-determined financial strategy rather than a lack of confidence in the company.
• Employees: The vesting schedule for options is tied to continuous service, which is a standard incentive mechanism for retaining key personnel.

Next Steps

• Remaining employee stock options are scheduled to vest in equal quarterly installments over specified periods, subject to the reporting person's continuous service through each vesting date.

Key Dates

Recommendation

The filing details a routine insider transaction (option exercise and subsequent sale) executed under a pre-established Rule 10b5-1 plan. Such planned sales are generally not indicative of new material information or a change in management's outlook on the company's fundamentals. Therefore, this specific filing alone does not provide sufficient new information to warrant a change from a 'hold' recommendation, assuming the investor's existing thesis on Stitch Fix remains unchanged.

Keywords

Stitch Fix, SFIX, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Rule 10b5-1 Plan, Executive Compensation, Anthony Bacos, Chief Product Officer, Chief Technology Officer